Clinical Experience with the Cervista HPV HR Assay Kenneth E. Youens, Gregory A. Hosler, Paula J. Washington, E. Patrick Jenevein, Kathleen M. Murphy The Journal of Molecular Diagnostics Volume 13, Issue 2, Pages 160-166 (March 2011) DOI: 10.1016/j.jmoldx.2010.11.016 Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions
Figure 1 Percent HR-HPV positive by cytologic interpretation. A: All samples. B: ASC-US. C: Women aged 30 years or older, NILM. All calculations are for reportable samples only. Whiskers indicate 95% confidence intervals. The Journal of Molecular Diagnostics 2011 13, 160-166DOI: (10.1016/j.jmoldx.2010.11.016) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions
Figure 2 HR-HPV positivity rates, stratified by age, for women aged 30 years or older with NILM cytologic interpretations, United States studies. Whiskers indicate 95% confidence intervals. *Reported in intervals of 10 years (ie, 30–39, 40–49, ≥50). The Journal of Molecular Diagnostics 2011 13, 160-166DOI: (10.1016/j.jmoldx.2010.11.016) Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions